JPH07330505A - Antimicrobial composition - Google Patents
Antimicrobial compositionInfo
- Publication number
- JPH07330505A JPH07330505A JP12635894A JP12635894A JPH07330505A JP H07330505 A JPH07330505 A JP H07330505A JP 12635894 A JP12635894 A JP 12635894A JP 12635894 A JP12635894 A JP 12635894A JP H07330505 A JPH07330505 A JP H07330505A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial
- antimicrobial
- substance
- composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 230000000845 anti-microbial effect Effects 0.000 title abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 39
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 14
- 239000003002 pH adjusting agent Substances 0.000 claims abstract description 11
- 229920005862 polyol Polymers 0.000 claims abstract description 9
- 150000003077 polyols Chemical class 0.000 claims abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 85
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 21
- 239000003755 preservative agent Substances 0.000 abstract description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 7
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 7
- 230000007815 allergy Effects 0.000 abstract description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 7
- 239000000284 extract Substances 0.000 abstract description 7
- 150000003839 salts Chemical class 0.000 abstract description 5
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 230000002070 germicidal effect Effects 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 14
- 238000002156 mixing Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003899 bactericide agent Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 239000013065 commercial product Substances 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000013566 allergen Substances 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 230000000774 hypoallergenic effect Effects 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 230000000622 irritating effect Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003206 sterilizing agent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- SJVGFKBLUYAEOK-SFHVURJKSA-N 6-[4-[(3S)-3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperidin-1-yl]pyrimidine-4-carbonitrile Chemical compound FC=1C=C(C=C(C=1)F)[C@@H]1CC=NN1C(=O)C1CCN(CC1)C1=CC(=NC=N1)C#N SJVGFKBLUYAEOK-SFHVURJKSA-N 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 240000007829 Haematoxylum campechianum Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 229960002326 bithionol Drugs 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- -1 isopropanol Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000006837 my medium Substances 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 239000004306 orthophenyl phenol Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007362 sporulation medium Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】この発明は抗菌性組成物に関し、
特には化粧品、医薬品、食品等に好適に用いることがで
きる抗菌性組成物に関する。This invention relates to an antibacterial composition,
In particular, it relates to an antibacterial composition that can be suitably used for cosmetics, pharmaceuticals, foods and the like.
【0002】[0002]
【従来の技術】現在、様々な分野において、微生物が原
因となって発生する製品の汚染もしくは変質を防止し、
製品の保存性を確保するために、種々の殺菌剤や防腐剤
が保存剤(もしくは保存料)として用いられている。こ
のうち、生体に直接適用し、もしくは生体が摂取する製
品分野、特に香粧品、医薬品、食品等の分野において
は、生体の安全性を確保するために、使用可能な保存剤
の種類や適用量が定められていることが多い。例えば、
香粧品の分野では、厚生省告示によって保存剤は安息香
酸( 0.2%)、安息香酸塩類( 1.0%)、サリチル酸
( 0.2%)、サリチル酸塩類( 1.0%)、石炭酸( 0.1
%)、ソルビン酸およびその塩類( 0.5%)、デヒドロ
酢酸およびその塩類( 0.5%)、パラオキシ安息香酸エ
ステル( 1.0%)、パラクロルメタクレゾール( 0.5
%)、ビチオノール( 0.1%)、ヘキサクロロフェン
( 0.1%)、ホウ酸( 0.5%)およびレゾルシン( 0.1
%)に定められており(括弧内は最高使用濃度)、これ
らは表示義務成分でもある。また、医薬品の分野では、
安息香酸、安息香酸ナトリウム、塩化ベンザルコニウ
ム、塩化ベンゼトニウム、クレゾール、クロロブタノー
ル、チモール、パラオキシ安息香酸メチル、パラオキシ
安息香酸エチル、パラオキシ安息香酸プロピル、パラオ
キシ安息香酸ブチル、フェノールおよびベンジルアルコ
ールが保存剤として日本薬局方に収載されている。さら
に、食品分野では毒性を有する物質は用いることができ
ず、保存料として用いられるのは安息香酸およびそのナ
トリウム塩、ソルビン酸およびそのカリウム塩、デヒド
ロ酢酸およびそのナトリウム塩、パラオキシ安息香酸お
よびそのエステル(エチル、プロピル、イソプロピル、
ブチル、イソブチル)、プロピオン酸およびそのナトリ
ウム塩もしくはカルシウム塩、ジフェニル、オルトフェ
ニルフェノール並びにチアベンダゾールにほぼ限られ
る。2. Description of the Related Art Currently, in various fields, prevention of contamination or deterioration of products caused by microorganisms,
Various bactericides and preservatives are used as preservatives (or preservatives) to ensure the storability of products. Among these, in the field of products directly applied to or ingested by the living body, particularly in the fields of cosmetics, pharmaceuticals, foods, etc., in order to ensure the safety of the living body, the types and application amounts of preservatives that can be used Is often set. For example,
In the field of cosmetics, the preservatives are benzoic acid (0.2%), benzoates (1.0%), salicylic acid (0.2%), salicylates (1.0%), carboxylic acid (0.1%) according to the Ministry of Health and Welfare notification.
%), Sorbic acid and its salts (0.5%), dehydroacetic acid and its salts (0.5%), paraoxybenzoic acid ester (1.0%), parachlorometacresol (0.5%)
%), Bithionol (0.1%), hexachlorophene (0.1%), boric acid (0.5%) and resorcinol (0.1%)
%) (The maximum concentration used in parentheses), and these are also mandatory ingredients. In the field of pharmaceuticals,
Benzoic acid, sodium benzoate, benzalkonium chloride, benzethonium chloride, cresol, chlorobutanol, thymol, methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, butyl paraoxybenzoate, phenol and benzyl alcohol as preservatives It is listed in the Japanese Pharmacopoeia. Further, in the food field, substances having toxicity cannot be used, and benzoic acid and its sodium salt, sorbic acid and its potassium salt, dehydroacetic acid and its sodium salt, paraoxybenzoic acid and its ester are used as preservatives. (Ethyl, propyl, isopropyl,
Butyl, isobutyl), propionic acid and its sodium or calcium salts, diphenyl, orthophenylphenol and thiabendazole.
【0003】しかし、このように種類や使用量を限定し
たとしても、これらの物質の多くは本質的に皮膚や全身
性のアレルギーを引き起こすアレルゲンであり、これら
の物質を適用することによりアレルギーを引き起こす恐
れがある。また、刺激性であったり、毒性を有するもの
も多い。However, even if the kind and the amount used are limited, many of these substances are essentially allergens causing skin and systemic allergies, and application of these substances causes allergies. There is a fear. In addition, many of them are irritating or toxic.
【0004】そこで、このような殺菌剤や防腐剤を用い
ずに抗菌力を持たせる試みが従来なされており、例え
ば、アルコールを配合する方法、フェノキシエタノール
を配合する方法、抗菌性のポリオールを用いる方法、抗
菌性の動植物由来の成分や抽出物を用いる方法などが知
られている。また、一般に、pH 2.5以下の酸性領域と
pH10.5以上のアルカリ性領域では抗菌性が高まること
が知られており、実際、食品等の分野では酸性になるよ
うにpHを調整して防腐能力を高める技術が広く用いら
れている。Therefore, attempts have been made so far to impart antibacterial activity without using such bactericides and preservatives. For example, a method of blending alcohol, a method of blending phenoxyethanol, and a method of using antimicrobial polyol. A method using an antibacterial animal or plant-derived component or extract is known. In addition, it is generally known that the antibacterial property is enhanced in the acidic region of pH 2.5 or lower and the alkaline region of pH 10.5 or higher. Boosting techniques are widely used.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、これら
アルコール、フェノキシエタノール、抗菌性ポリオー
ル、抗菌性抽出物等を配合する方法では十分な抗菌力を
得ることはできず、室温では使用途中で腐敗したり、カ
ビが生えたりする。このため、これらの方法を用いて製
造した組成物は、製造時に微生物が混入しないように無
菌製造を行なうと共に、微生物が混入しにくい容器や使
い捨てタイプの小容器に収容したり、開封後の冷蔵保存
や使用期間の短期限定等の方法によって抗菌力の不足に
対応している。However, the method of blending these alcohols, phenoxyethanol, antibacterial polyols, antibacterial extracts and the like cannot obtain sufficient antibacterial activity, and at room temperature, it may rot during use, Mold will grow. Therefore, the composition produced by using these methods, aseptic manufacturing so as not to be mixed with microorganisms at the time of manufacture, and stored in a container or a disposable type small container in which microorganisms are difficult to mix, refrigerated after opening. We cope with the lack of antibacterial activity by methods such as storage and short-term use.
【0006】また、組成物を酸性(pH 2.5以下)やア
ルカリ性(pH10.5以上)とする方法では、組成物に十
分な抗菌力を付与することが可能であるが、このような
組成物は生体、特に皮膚や粘膜に対する刺激が強く、特
殊な用途を除いて一般の組成物に適用することはできな
い。Further, a method of making the composition acidic (pH 2.5 or less) or alkaline (pH 10.5 or more) can impart sufficient antibacterial activity to the composition, but such a composition is It is highly irritating to the living body, especially the skin and mucous membranes, and cannot be applied to general compositions except for special applications.
【0007】したがって、この発明は、毒性や刺激性を
有していたり、アレルギーを引き起こすアレルゲンとな
るような、生体、特に人体に害を及ぼす可能性のある殺
菌剤や防腐剤を用いることなく、これら殺菌剤や防腐剤
を用いた場合と同等かそれ以上の抗菌力を長期間保持し
得る、低アレルギー性、低刺激性かつ低毒性の抗菌性組
成物を提供することを目的とする。Therefore, the present invention does not use a bactericidal agent or an antiseptic agent which is toxic or irritating, or which may be an allergen causing allergies, which may harm the living body, particularly the human body. It is an object of the present invention to provide a hypoallergenic, hypoallergenic, and low-toxicity antibacterial composition capable of retaining an antibacterial activity equivalent to or higher than those obtained by using these fungicides and preservatives for a long period of time.
【0008】[0008]
【課題を解決するための手段】本発明者は、上記事情に
鑑み、鋭意研究の結果、特定のpH条件の下で殺菌剤も
しくは防腐剤以外の抗菌性物質の少なくとも1種類を用
いるか、あるいは殺菌剤もしくは防腐剤以外の抗菌性物
質の少なくとも2種類を組み合わせて用いることにより
実用に足る十分な抗菌力を得ることが可能であることを
見出し、この発明をなすに至った。In view of the above circumstances, the present inventors have made earnest studies and, as a result, have used at least one antibacterial substance other than a bactericide or a preservative under a specific pH condition, or The inventors have found that it is possible to obtain a practically sufficient antibacterial activity by using at least two kinds of antibacterial substances other than bactericides or antiseptics in combination, and completed the present invention.
【0009】すなわち、この発明の一面における抗菌性
組成物は、pH調整剤および抗菌性物質からなる群より
選ばれる少なくとも2種類を含有する組成物であって、
前記pH調整剤は組成物のpHを 2.8ないし 7.0とする
ものであることを特徴とする。ここで用いられる抗菌性
物質は、好ましくはフェノキシエタノールおよび抗菌性
ポリオールである。That is, the antibacterial composition according to one aspect of the present invention is a composition containing at least two kinds selected from the group consisting of a pH adjuster and an antibacterial substance,
The pH adjuster is characterized in that the pH of the composition is 2.8 to 7.0. The antibacterial substances used here are preferably phenoxyethanol and antibacterial polyols.
【0010】また、この発明の他の面における抗菌性組
成物は、少なくとも1種の抗菌性物質を含有し、かつp
Hが 2.8ないし 7.0であることを特徴とする。An antibacterial composition according to another aspect of the present invention contains at least one antibacterial substance, and p
Characterized by H being 2.8 to 7.0.
【0011】ここで言う「抗菌性物質」とは、従来、香
粧品、医薬品、食品等の分野において広く用いられ、単
独で組成物に十分な抗菌力を付与することが可能ではあ
るものの、毒性や刺激性を有していたり、アレルギーを
引き起こすアレルゲンとなるような、生体、特に人体に
害を及ぼす可能性のある殺菌剤や防腐剤を除く抗菌性の
物質を指す。この発明においては、抗菌性物質は、天然
由来の物質または合成物質のいずれであってもよい。具
体的には、天然由来の抗菌性物質の例として、動物由来
の物質もしくは抽出物としてミツロウ、プロポリス、ロ
ーヤルゼリー、乳精、馬油、ヒドロキシ酢酸、キチン、
キトサン、ペプチド等を挙げることができ、また植物由
来の物質もしくは抽出物としてアロエ、オウゴン、オウ
セイ、オウバク、エンメイソウ、クジン、ゲンノショウ
コウ、サンザシ、サンシン、サンショウ、シコン、シ
ソ、ジュウヤク、ソウハクヒ、トウキ、ニンジン、ニン
ドウ、ニンニク、バクモンドウ、ビャクト、ビワ、モ
モ、ユキノシタ、レンギョウ、ログウッド、アルニカ、
オトギソウ、カミツレ、サルビア、シャクヤク、ショウ
ブ、シラカバ、セイヨウノコギリソウ、センキュウ、タ
イム、トウキンセンカ、ハマメリス、ホップ、ヨモギ、
カワラヨモギ、ラベンダー、レモンおよびローズマリー
の抽出物、カンゾウフラボノイド、α- ビサボロール、
ペプチド等を挙げることができる。また、合成抗菌性物
質の例としては、エタノール、イソプロパノール等の低
級アルコール、1,3-ブチレングリコール、ジプロピレン
グリコール、3-メチル-1,3- ブタンジオール等の抗菌性
ポリオール、フェノキシエタノール、α- ヒドロキシ酸
等を挙げることができる。この発明において好ましい抗
菌性物質は、抗菌性ポリオールまたはフェノキシエタノ
ールである。The term "antibacterial substance" as used herein is conventionally widely used in the fields of cosmetics, pharmaceuticals, foods, etc., and although it is possible to impart sufficient antibacterial activity to the composition by itself, it is toxic. It refers to an antibacterial substance excluding bactericides and preservatives, which have an irritating property or become an allergen that causes allergies, which may harm the living body, especially the human body. In the present invention, the antibacterial substance may be a naturally occurring substance or a synthetic substance. Specifically, as an example of a naturally derived antibacterial substance, beeswax, propolis, royal jelly, milk sperm, horse oil, hydroxyacetic acid, chitin, as an animal-derived substance or extract,
Chitosan, peptides and the like can be mentioned, and as a plant-derived substance or extract, aloe, sardine, eucalyptus, pearl oyster, neem grass, kujin, ginger ginger, hawthorn, sanshin, ginseng, shikon, perilla, sycamore, sowakuhi, touki. , Carrot, nindou, garlic, bakumondo, juniper, loquat, peach, yukinoshita, forsythia, logwood, arnica,
Hypericum, chamomile, salvia, peony, ginger, birch, yarrow, senkyu, thyme, quince, hamamelis, hop, mugwort,
Kawamurawoge, lavender, lemon and rosemary extract, licorice flavonoids, α-bisabolol,
Examples thereof include peptides. Examples of synthetic antibacterial substances include ethanol, lower alcohols such as isopropanol, antibacterial polyols such as 1,3-butylene glycol, dipropylene glycol, and 3-methyl-1,3-butanediol, phenoxyethanol, α- A hydroxy acid etc. can be mentioned. The preferred antibacterial substance in the present invention is an antibacterial polyol or phenoxyethanol.
【0012】これらの抗菌性物質の配合量は組成物の剤
形や処方によって異なり、抗菌力、安全性、感触、外
観、物性等を考慮して決定されるものであって一概に特
定できるものではないが、一般に、用いられる抗菌性物
質の合計で、組成物全体に対して 0.0101 〜 100.0重量
%である。また、個々の抗菌性物質については、組成物
全体に対して、ミツロウでは 0.1〜50.0、好ましくは
0.5〜 5.0重量%、プロポリスでは0.01〜99.9、好まし
くは 0.1〜10.0重量%、ローヤルゼリーでは0.01〜99.
9、好ましくは 0.1〜10.0重量%、乳精では 0.1〜99.
9、好ましくは 0.1〜50.0重量%、馬油では 0.1〜99.
9、 0.1〜99.0重量%、ペプチドでは0.01〜99.9、好ま
しくは 0.1〜99.0重量%、キチンでは0.01〜99.9、好ま
しくは 0.1〜99.0重量%、キトサンでは0.01〜99.9、好
ましくは 0.1〜99.0重量%、植物由来の各種抽出物では
0.01〜99.9、カンゾウフラボノイドでは0.0001〜 5.0、
好ましくは 0.001〜 1.0重量%、α- ビサボロールでは
0.1〜 2.0、好ましくは 0.1〜 1.0重量%、低級アルコ
ールでは 1.0〜99.9、好ましくは 2.0〜50.0重量%、抗
菌性ポリオールでは 1.0〜99.9、好ましくは 2.0〜50.0
重量%、フェノキシエタノールでは 0.1〜 5.0、好まし
くは 0.1〜 1.0重量%、α- ヒドロキシ酸では0.01〜2
0.0、好ましくは 0.01 〜 5.0重量%、pH調整剤では
0.01〜20.0、好ましくは0.01〜 5.0重量%である。The blending amount of these antibacterial substances differs depending on the dosage form and prescription of the composition, and is determined in consideration of antibacterial activity, safety, feel, appearance, physical properties, etc., and can be generally specified. However, the total amount of antibacterial substances used is generally 0.0101 to 100.0% by weight, based on the total composition. Further, for each antibacterial substance, beeswax is 0.1 to 50.0 with respect to the entire composition, preferably
0.5 to 5.0% by weight, 0.01 to 99.9 in propolis, preferably 0.1 to 10.0% by weight, 0.01 to 99 in royal jelly.
9, preferably 0.1-10.0% by weight, for milk semen 0.1-99.
9, preferably 0.1-50.0% by weight, for horse oil 0.1-99.
9, 0.1-99.0 wt%, 0.01-99.9, preferably 0.1-99.0 wt% for peptides, 0.01-99.9, preferably 0.1-99.0 wt% for chitin, 0.01-99.9 for chitosan, preferably 0.1-99.0 wt%, In various plant-derived extracts
0.01-99.9, licorice flavonoids 0.0001-5.0,
Preferably 0.001-1.0% by weight, for α-bisabolol
0.1-2.0, preferably 0.1-1.0 wt%, lower alcohol 1.0-99.9, preferably 2.0-50.0 wt%, antimicrobial polyol 1.0-99.9, preferably 2.0-50.0
% By weight, 0.1-5.0% by weight for phenoxyethanol, preferably 0.1-1.0% by weight, 0.01-2 for α-hydroxy acids.
0.0, preferably 0.01 to 5.0% by weight, for pH adjusters
It is 0.01 to 20.0, preferably 0.01 to 5.0% by weight.
【0013】この発明の抗菌性組成物は、上記抗菌性物
質から選ばれる少なくとも2種類の物質を含有するか、
もしくは上記抗菌性物質から選ばれる少なくとも1種類
の物質をpH 2.8〜 7.0の条件下に含有する。The antibacterial composition of the present invention contains at least two kinds of substances selected from the above antibacterial substances,
Alternatively, it contains at least one substance selected from the above antibacterial substances under the condition of pH 2.8 to 7.0.
【0014】この発明においては、組成物のpHを 2.8
〜 7.0とするために、pH調整剤を用いることができ
る。用いられるpH調整剤は、組成物のpHを 2.8〜
7.0、好ましくはpH 3.5〜 6.5に調整し得るものであ
ればどのようなものでもよく、各分野において通常用い
られるものを使用することができる。組成物のpHは上
記範囲内に収まっていればよいが、抗菌性の点からはよ
り低いほうが好ましい。この発明において用いられるp
H調整剤は、好ましくは無機酸もしくは有機酸またはそ
れらの塩であり、有機酸の例としてはクエン酸、グリコ
ール酸、コハク酸、酒石酸、乳酸、リンゴ酸、酪酸およ
びシュウ酸を、また無機酸の例としてはリン酸および塩
酸をそれぞれ挙げることができ、さらにこれらの酸のナ
トリウム塩、カリウム塩、カルシウム塩等を好適に用い
ることができる。特に好ましくは、pH調整剤はクエン
酸またはその塩である。In the present invention, the pH of the composition is 2.8.
A pH adjuster can be used to achieve ~ 7.0. The pH adjuster used has a composition pH of 2.8 to
Any one can be used as long as it can be adjusted to 7.0, preferably pH 3.5 to 6.5, and those usually used in each field can be used. The composition may have a pH within the above range, but it is preferably lower from the viewpoint of antibacterial property. P used in this invention
The H-adjusting agent is preferably an inorganic acid or an organic acid or a salt thereof, and examples of the organic acid include citric acid, glycolic acid, succinic acid, tartaric acid, lactic acid, malic acid, butyric acid and oxalic acid, and inorganic acid. Examples thereof include phosphoric acid and hydrochloric acid, and sodium salts, potassium salts, calcium salts and the like of these acids can be preferably used. Particularly preferably, the pH adjusting agent is citric acid or a salt thereof.
【0015】なお、上記抗菌性物質または組成物の処方
構成成分により組成物のpHが必然的に上記範囲内に収
まる場合には、特にpH調整剤を用いる必要はない。When the pH of the composition inevitably falls within the above range due to the antibacterial substance or the formulation constituents of the composition, it is not necessary to use a pH adjuster.
【0016】これらpH調整剤の配合量は、組成物のp
Hを 2.8〜 7.0に調整するに十分な量であればよく、組
成物の剤形、処方によって最適の配合量が決定される。
したがって、一概に特定できるものではないが、通常、
組成物全体に対して0.01〜 5.0重量%である。The blending amount of these pH adjusting agents is the p of the composition.
The amount may be a sufficient amount to adjust H to 2.8 to 7.0, and the optimum compounding amount is determined by the dosage form and formulation of the composition.
Therefore, although it cannot be specified unconditionally,
It is 0.01 to 5.0% by weight with respect to the entire composition.
【0017】この発明による抗菌性組成物においては、
上記成分のほかに、各分野で通常用いられるいかなる添
加物も添加することができるが、微生物の増殖を助長す
る成分は、組成物の抗菌力を損なわない程度にまで制限
することが好ましい。In the antibacterial composition according to the present invention,
In addition to the above-mentioned components, any additives usually used in each field can be added, but components that promote the growth of microorganisms are preferably limited to the extent that the antibacterial activity of the composition is not impaired.
【0018】この発明による抗菌性組成物の形態として
は、含水タイプ、粉末タイプ、固形粉末タイプ、オイル
タイプなどを挙げることができる。含水タイプの組成物
は、水を含むものであればどのようなものでもよく、例
えば、乳化タイプ、可溶化タイプ、溶液タイプ、分散タ
イプ、ゲルタイプを挙げることができる。Examples of the form of the antibacterial composition according to the present invention include water-containing type, powder type, solid powder type and oil type. The water-containing composition may be any composition as long as it contains water, and examples thereof include an emulsification type, a solubilization type, a solution type, a dispersion type and a gel type.
【0019】この発明による抗菌性組成物はいかなる分
野においても用いることができるが、特に香粧品、医薬
品、食品等の分野において、例えば基材や担体として好
適に用いることができる。また、微生物やアレルギーが
関与する疾患、例えば、ニキビ、フケ、ワキガ、炎症、
水虫、アトピー等の症状の改善に用いることもできる。
さらに、消毒や殺菌に用いることも可能である。The antibacterial composition according to the present invention can be used in any field, but particularly in the fields of cosmetics, pharmaceuticals, foods, etc., it can be preferably used as a base material or carrier. In addition, diseases related to microorganisms and allergies, such as acne, dandruff, armpits, inflammation,
It can also be used to improve symptoms such as athlete's foot and atopy.
Further, it can be used for disinfection and sterilization.
【0020】[0020]
【実施例】以下、この発明による抗菌性組成物を、実施
例に基づいてより詳細に説明する。EXAMPLES Hereinafter, the antibacterial composition according to the present invention will be described in more detail with reference to Examples.
【0021】実施例1〜5および比較例1〜3 下記表1に示す各組成のローションを下記A)に記す製
法に従って調製した。次に、得られたローションの抗菌
力を、大腸菌および黒コウジカビを用い、下記B)に記
す方法により測定した。その結果を表1に併記する。Examples 1 to 5 and Comparative Examples 1 to 3 Lotions having the respective compositions shown in Table 1 below were prepared according to the production method described in A) below. Next, the antibacterial activity of the obtained lotion was measured using E. coli and Aspergillus niger by the method described in B) below. The results are also shown in Table 1.
【0022】A)製法 表1に示す各組成の全成分を秤量し、約80℃に加熱して
均一に混合した後、冷却して検体とした。なお、操作は
無菌的に行なった。A) Manufacturing method All components of each composition shown in Table 1 were weighed, heated to about 80 ° C. and uniformly mixed, and then cooled to obtain a sample. The operation was performed aseptically.
【0023】B)抗菌力測定方法 (1) 大腸菌を用いた試験 前々培養36時間、前培養24時間および本培養 5時間を行
なうことにより 1コロニーから均質な菌体を得た。次い
で、この菌体を遠沈洗浄し、リン酸緩衝生理食塩水で 7
×108 [CFU]に調整して接種菌液とした。その後、
この接種菌液を上記A)で調製した各検体に 1%添加
し、37℃の水槽に保持して生菌数を経時的に測定した。B) Method for measuring antibacterial activity (1) Test using Escherichia coli Homogeneous cells were obtained from one colony by pre-preculture 36 hours, preculture 24 hours and main culture 5 hours. Then, the cells were washed by centrifugation and washed with phosphate buffered saline.
It was adjusted to × 10 8 [CFU] to give an inoculum solution. afterwards,
This inoculum solution was added to each sample prepared in A) above in an amount of 1% and kept in a water bath at 37 ° C to measure the viable cell count over time.
【0024】実施条件 前々培養・前培養 : SCDアガー、37℃ 本培養 : SCDブイヨン、50rpm rec
iprocal 、37℃ 供試菌株 : Escherichia coli IAM 12119 生菌数測定用培地 : SCDLPアガー 抗菌力の判定は、殺菌・防腐剤が配合された市販品のロ
ーション(複数)を基準とし、以下の通りに行なった。Preconditions Pre-preculture / preculture: SCD agar, 37 ° C main culture: SCD broth, 50 rpm rec
iprocal, 37 ° C Test strain: Escherichia coli IAM 12119 Viable count medium: SCDLP agar The antibacterial activity is determined based on the lotion (several) of a commercially available product containing a bactericidal / preservative agent as follows. I did.
【0025】 市販品と同等以上の抗菌力 : ◎ 市販品と同等の抗菌力 : ○ 市販品より低い抗菌力または菌が増殖するもの : × (2) 黒コウジカビを用いた試験 7日間の培養で得られた分生胞子を収穫し、0.01% Twee
n 80 添加生理食塩水中に分散した後濾過して 3×107
spore/mlに調整したものを接種菌液とした。この接
種菌液を上記A)で調製した各検体に 1%添加し、27℃
インキュベーターに保持して生菌数を経時的に測定する
と共に菌糸の繁殖を観察した。Antibacterial activity equal to or higher than that of the commercial product: ◎ Antibacterial activity equivalent to that of the commercial product: ○ Antibacterial activity lower than that of the commercial product or bacteria growing: × (2) Test using black mold The conidia obtained are harvested and 0.01% Twee
n 80 3 Dispersed in physiological saline, filtered, and filtered 3 × 10 7
The inoculum solution was adjusted to spore / ml. Add 1% of this inoculum to each sample prepared in A) above,
The cells were kept in an incubator to measure the viable cell count over time and the growth of hyphae was observed.
【0026】実施条件 胞子形成培地 : MY培地 供試菌株 : Aspergillus niger IFO 4407 生菌数測定用培地 : GPLPアガー 抗菌力の判定は、殺菌・防腐剤が配合された市販品のロ
ーション(複数)を基準とし、以下の通りに行なった。Implementation conditions Sporulation medium: MY medium Test strain: Aspergillus niger IFO 4407 Medium for viable cell count: GPLP agar To determine the antibacterial activity, use lotion (s) of a commercial product containing a bactericidal / preservative agent. As a reference, the procedure was as follows.
【0027】 市販品と同等以上の抗菌力 : ◎ 市販品と同等の抗菌力 : ○ 抗菌性はあるが、市販品より劣るもの : △ 抗菌性がなく、菌が発芽・増殖するもの : ×Antibacterial activity equal to or higher than commercial products: ◎ Antibacterial activity equivalent to commercial products: ○ Antibacterial properties, but inferior to commercial products: △ No antibacterial properties, germs germinate and multiply: ×
【表1】 表1から明らかなように、この発明による抗菌性組成物
は、大腸菌および黒コウジカビのいずれに対しても殺菌
・防腐剤が配合された市販品と同等以上の優れた抗菌力
を示している。これに対し、比較例の組成物はいずれも
十分な抗菌力が得られず、市販に耐え得るレベルのもの
ではなかった。[Table 1] As is clear from Table 1, the antibacterial composition according to the present invention exhibits superior antibacterial activity to both E. coli and Aspergillus niger, which is equal to or higher than that of a commercial product containing a bactericidal / preservative. On the other hand, none of the compositions of Comparative Examples had a sufficient antibacterial activity and were not at a level that could withstand commercial use.
【0028】実施例6 下記処方のクリームを下記製法に従って調製した。Example 6 A cream having the following formulation was prepared according to the following production method.
【0029】 処 方 配合量 (重量%) −−−−−−−−−−−−−−−−−−−−−−−− −−−−− (1) ミツロウ 5.0 (2) ベヘニルアルコール 4.0 (3) 流動パラフィン 20.0 (4) モノステアリン酸グリセリン 5.0 (5) ポリオキシエチレンモノステアリン酸ソルビタン 3.0 (6) フェノキシエタノール 0.5 (7) クエン酸 0.02 (8) 1,3-ブチレングリコール 7.0 (9) 精製水 55.48 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 3.8 製法) (i) 上記処方の (1)〜 (6)を75℃で加熱溶解する。Treatment Mixing amount (% by weight) ------------------------------ (1) Beeswax 5.0 (2) Behenyl alcohol 4.0 (3) Liquid paraffin 20.0 (4) Glycerin monostearate 5.0 (5) Polyoxyethylene sorbitan monostearate 3.0 (6) Phenoxyethanol 0.5 (7) Citric acid 0.02 (8) 1,3-Butylene glycol 7.0 (9) Purified water 55.48 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− --- pH 3.8 manufacturing method) (i) (1) to (6) of the above formulation are heated and dissolved at 75 ° C.
【0030】(ii) (i) とは別に上記処方の (7)〜 (9)
を75℃で加熱溶解する。(Ii) (7) to (9) of the above formulation separately from (i)
Is melted by heating at 75 ° C.
【0031】(iii) 上記 (i)の調製物に (ii) の調製物
を加えて乳化・冷却する。(Iii) The preparation of (ii) is added to the preparation of (i) above, and the mixture is emulsified and cooled.
【0032】実施例7 下記処方の美容液を下記製法に従って調製た。Example 7 A beauty essence having the following formulation was prepared according to the following production method.
【0033】 処 方 配合量 (重量%) −−−−−−−−−−−−− −−−−− (1) 植物抽出液 1.0 (2) ソルビット 3.0 (3) グリセリン 3.0 (4) ヒアルロン酸ナトリウム 0.03 (5) キサンタンガム 1.0 (6) フェノキシエタノール 0.4 (7) クエン酸 0.2 (8) 1,3-ブチレングリコール 10.0 (9) 精製水 81.37 −−−−−−−−−−−−−−−−−−−−−−−−−− pH 4.8 製法) (i) 上記処方の (1)〜 (3)および (6)〜 (9)を70℃で
加熱・溶解する。Treatment Mixing amount (% by weight) ----------------------- (1) Plant extract 1.0 (2) Sorbit 3.0 (3) Glycerin 3 .0 (4) sodium hyaluronate 0.03 (5) xanthan gum 1.0 (6) phenoxyethanol 0.4 (7) citric acid 0.2 (8) 1,3-butylene glycol 10.0 (9) purified water 81.37 −−−−−−−−−−−−−−−−−−−−−−−−−− pH 4.8 Manufacturing method) (i) (1) to (3) and (3) of the above formulation. 6)-(9) are heated and melted at 70 ℃.
【0034】(ii) 上記処方の (4)および (5)を撹拌し
ながら (i)の調製物に加えて均一に溶解し、冷却する。(Ii) (4) and (5) of the above formulation are added to the preparation of (i) with stirring, uniformly dissolved, and cooled.
【0035】実施例8 下記処方の洗浄料を下記製法に従って調製した。Example 8 A cleaning agent having the following formulation was prepared according to the following production method.
【0036】 処 方 配合量 (重量%) −−−−−−−−−−−−−−−−−−−−−− −−−−− (1) ラウロイル-L- グルタミン酸トリエタノール 60.0 (2) ヤシ油脂肪酸アミドプロピルベタイン 10.0 (3) アラントイン 0.1 (4) クエン酸 0.3 (5) フェノキシエタノール 0.5 (6) 精製水 29.1 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 5.3 製法)上記処方の (1)〜 (7)を室温で撹拌して均一に溶
解する。Method Blending amount (% by weight) --------------------------- (1) Lauroyl-L-Glutamic acid triethanol 60. 0 (2) Coconut oil fatty acid amide propyl betaine 10.0 (3) Allantoin 0.1 (4) Citric acid 0.3 (5) Phenoxyethanol 0.5 (6) Purified water 29.1 -------- -------------------------------- pH 5.3 Manufacturing method) (1) to (7) of the above formulation are stirred at room temperature to uniformly dissolve.
【0037】実施例9 下記処方のジェルを下記製法に従って調製した。Example 9 A gel having the following formulation was prepared according to the following production method.
【0038】 処 方 配合量 (重量%) −−−−−−−−−−−−−−−−−−−− −−−−− (1) カルボキシビニルポリマー( 1% aq.) 60.0 (2) コラーゲン( 0.3%) 2.0 (3) ヒアルロン酸ナトリウム( 1%) 5.0 (4) アラントイン 0.1 (5) 植物抽出液 3.0 (6) フェノキシエタノール 0.4 (7) 1,3-ブチレングリコール 10.0 (8) 精製水 19.5 −−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 6.3 製法)上記処方の (1)〜 (8)を撹拌して均一に溶解す
る。Method Mixing amount (% by weight) ------------------ (1) Carboxyvinyl polymer (1% aq.) 60. 0 (2) Collagen (0.3%) 2.0 (3) Sodium hyaluronate (1%) 5.0 (4) Allantoin 0.1 (5) Plant extract 3.0 (6) Phenoxyethanol 0.4 (7) ) 1,3-Butylene glycol 10.0 (8) Purified water 19.5 ------------------------------ pH 6. 3 Manufacturing method) (1) to (8) of the above formulation are stirred and uniformly dissolved.
【0039】実施例10 下記処方のクリームを下記製法に従って調製した。Example 10 A cream having the following formulation was prepared according to the following production method.
【0040】 処 方 配合量 (重量%) −−−−−−−−−−−−−−−−−−−−−−−− −−−−− (1) ミツロウ 5.0 (2) ベヘニルアルコール 4.0 (3) 吸着精製ラノリン 15.0 (4) 流動パラフィン 25.0 (5) ステアリン酸ナトリウム 5.0 (6) ポリオキシエチレンモノステアリン酸ソルビタン 3.0 (7) 1,3-ブチレングリコール 7.0 (8) 精製水 36.0 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 4.0 製法) (i) 上記処方の (1)〜 (6)を75℃で加熱溶解する。Treatment Mixing amount (% by weight) ------------------------------------- (1) Beeswax 5.0 (2) Behenyl alcohol 4.0 (3) Adsorption purified lanolin 15.0 (4) Liquid paraffin 25.0 (5) Sodium stearate 5.0 (6) Polyoxyethylene sorbitan monostearate 3.0 (7) 1,3- Butylene glycol 7.0 (8) Purified water 36.0 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 4.0 Manufacturing method (I) (1) to (6) of the above formulation are heated and dissolved at 75 ° C.
【0041】(ii) (i) とは別に上記処方の (7)および
(8)を75℃で加熱溶解する。(Ii) Apart from (i), (7) and
(8) is melted by heating at 75 ° C.
【0042】(iii) (i) の調製物に (ii) の調製物を加
えて乳化、冷却する。(Iii) The preparation of (ii) is added to the preparation of (i), and the mixture is emulsified and cooled.
【0043】実施例11 下記処方のミルクローションを下記製法に従って調製し
た。Example 11 A milk lotion having the following formulation was prepared according to the following method.
【0044】 処 方 配合量 (重量%) −−−−−−−−−−−−−−−−−−−−−−−− −−−−− (1) ステアリン酸 4.0 (2) ベヘニルアルコール 4.0 (3) 流動パラフィン 5.0 (4) ステアリン酸モノグリセリン 4.0 (5) ポリオキシエチレンモノステアリン酸ソルビタン 2.0 (6) フェノキシエタノール 0.3 (7) クエン酸 0.1 (8) クエン酸ナトリウム 0.1 (9) 1,3-ブチレングリコール 6.0 (10)精製水 74.5 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− pH 4.6 製法) (i) 上記処方の (1)〜 (6)を75℃で加熱溶解する。Treatment Mixing amount (% by weight) ------------------------------ (1) Stearic acid 4.0 (2) ) Behenyl alcohol 4.0 (3) Liquid paraffin 5.0 (4) Monoglycerin stearate 4.0 (5) Polyoxyethylene sorbitan monostearate 2.0 (6) Phenoxyethanol 0.3 (7) Citric acid 0.0. 1 (8) Sodium citrate 0.1 (9) 1,3-butylene glycol 6.0 (10) Purified water 74.5 −−−−−−−−−−−−−−−−−−−−−− --------------- pH 4.6 Manufacturing Method) (i) (1) to (6) of the above formulation are heated and dissolved at 75 ° C.
【0045】(ii) (i) とは別に、上記処方の (7)〜(1
0)を75℃で加熱溶解する。(Ii) In addition to (i), (7) to (1
0) is heated and melted at 75 ° C.
【0046】(iii) (i) の調製物に (ii) の調製物を加
えて乳化、冷却する。(Iii) The preparation of (ii) is added to the preparation of (i), and the mixture is emulsified and cooled.
【0047】上記実施例6〜11において調製した美容
液、洗浄料、ジェル、クリームおよびミルクローション
の抗菌力を、上記実施例1および2と同様の方法で判定
した。その結果を下記表2に示す。The antibacterial activity of the beauty essences, detergents, gels, creams and milk lotions prepared in Examples 6 to 11 was determined in the same manner as in Examples 1 and 2 above. The results are shown in Table 2 below.
【0048】 表 2 実 施 例 −−−−−−−−−−−−−−−−−− 6 7 8 9 10 11 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 大腸菌に対する抗菌力 ○ ◎ ○ ○ ○ ◎ 黒コウジカビに対する抗菌力 ◎ ◎ ◎ ◎ ○ ◎ 表2より明らかなように、この発明による抗菌性組成物
は、大腸菌および黒コウジカビのいずれに対しても殺菌
・防腐剤が配合された市販品と同等以上の優れた抗菌力
を示す。また、これらの組成物は、この他にも緑膿菌、
黄色ブドウ球菌および枯草菌に対しても優れた抗菌力を
示す。Table 2 Actual Example -------------------------------- 6 7 8 9 10 11 -------------------- −−−−−−−−−−−−−−− Antibacterial activity against E. coli ○ ◎ ○ ○ ○ ◎ Antibacterial activity against Aspergillus niger ◎ ◎ ◎ ◎ ○ ○ ◎ As is clear from Table 2, the antibacterial composition according to the present invention. The product shows excellent antibacterial activity equivalent to or higher than that of a commercial product containing a sterilizing / preservative agent against both Escherichia coli and Aspergillus niger. In addition, these compositions also include Pseudomonas aeruginosa,
Excellent antibacterial activity against Staphylococcus aureus and Bacillus subtilis.
【0049】[0049]
【発明の効果】以上のように、この発明によると、低ア
レルギー、低刺激性かつ低毒性の抗菌性組成物が提供さ
れる。この抗菌性組成物は、毒性や刺激性を有していた
り、アレルギーを引き起こすアレルゲンとなるような、
生体に害を及ぼす可能性のある従来の殺菌剤や防腐剤を
用いることなく、十分な抗菌力を発揮する。As described above, according to the present invention, a hypoallergenic, hypoallergenic and low-toxicity antibacterial composition is provided. This antibacterial composition has toxicity or irritation, or becomes an allergen that causes allergies,
It exerts sufficient antibacterial activity without the use of conventional bactericides and preservatives that may harm the living body.
【0050】この発明による抗菌性組成物は、香粧品、
医薬品、食品等に好適に用いることができ、特に香粧品
に用いた場合には、厚生省告示によって定められ、かつ
表示義務を有する殺菌・防腐剤を含有せずに十分な抗菌
力を得ることができるため、「無添加化粧品」と称する
ことが可能であり、しかも使用期限、用いる容器、冷蔵
保存の必要性など無添加に伴う制約を受けることがな
い。The antibacterial composition according to the present invention is a cosmetic product,
It can be suitably used for medicines, foods, etc., and particularly when used for cosmetics, it is possible to obtain sufficient antibacterial activity without containing a sterilizing / preservative agent that is stipulated by the Ministry of Health and Welfare notification and has a labeling obligation. Therefore, it can be referred to as "additive-free cosmetics", and is not subject to restrictions such as expiration date, container to be used, need for refrigerated storage, and the like.
Claims (3)
り選ばれる少なくとも2種類の物質を含有する抗菌性組
成物であって、該pH調整剤は該組成物のpHを 2.8な
いし7.0とするものである抗菌性組成物。1. An antibacterial composition containing at least two kinds of substances selected from the group consisting of a pH adjusting agent and an antibacterial substance, wherein the pH adjusting agent adjusts the pH of the composition to 2.8 to 7.0. An antibacterial composition which is
つそのpHが 2.8ないし 7.0である抗菌性組成物。2. An antibacterial composition containing at least one antibacterial substance and having a pH of 2.8 to 7.0.
抗菌性ポリオールからなる群より選ばれる少なくとも2
種類の物質を含有する抗菌性組成物であって、該pH調
整剤は該組成物のpHを 2.8ないし 7.0とするものであ
る抗菌性組成物。3. At least 2 selected from the group consisting of pH adjusters, phenoxyethanol and antibacterial polyols.
An antibacterial composition containing different types of substances, wherein the pH adjuster adjusts the pH of the composition to 2.8 to 7.0.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12635894A JPH07330505A (en) | 1994-06-08 | 1994-06-08 | Antimicrobial composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12635894A JPH07330505A (en) | 1994-06-08 | 1994-06-08 | Antimicrobial composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07330505A true JPH07330505A (en) | 1995-12-19 |
Family
ID=14933211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12635894A Pending JPH07330505A (en) | 1994-06-08 | 1994-06-08 | Antimicrobial composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07330505A (en) |
Cited By (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0920630A (en) * | 1995-07-06 | 1997-01-21 | Nippon Zetotsuku Kk | Cosmetic material |
| JPH0952814A (en) * | 1995-08-09 | 1997-02-25 | Sunstar Inc | Skin cosmetic composition |
| JPH09255519A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH09255517A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH09255518A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH1045556A (en) * | 1996-08-02 | 1998-02-17 | Noevir Co Ltd | Antimicrobial and low-irritant cosmetic |
| JPH1045562A (en) * | 1996-08-08 | 1998-02-17 | Noevir Co Ltd | Antimicrobial and low-irritant cosmetic |
| JPH1053510A (en) * | 1996-05-27 | 1998-02-24 | Shiseido Co Ltd | Composition for external use |
| JPH10139601A (en) * | 1996-11-13 | 1998-05-26 | Noevir Co Ltd | Antimicrobial and antimicrobial cosmetic material containing the same |
| JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
| JPH10194948A (en) * | 1997-01-17 | 1998-07-28 | Nippon Shizen Shokuhin Kk | Skin lotion |
| JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
| JPH10194923A (en) * | 1997-01-13 | 1998-07-28 | Nippon Zetotsuku Kk | Emulsified composition |
| JPH10203955A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| JPH10203991A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Preparation for external use for skin |
| JPH10279417A (en) * | 1997-04-01 | 1998-10-20 | Shiseido Co Ltd | Preparation for external use for skin |
| EP0771561A3 (en) * | 1995-10-30 | 1999-03-17 | Beiersdorf Aktiengesellschaft | Antimycotic compositions, especially active against dandruff, containing aromatic alcohols |
| JPH1180781A (en) * | 1997-09-11 | 1999-03-26 | Narisu Keshohin:Kk | Cleaning composition for atopic dermatitis |
| US5900258A (en) * | 1996-02-01 | 1999-05-04 | Zeolitics Inc. | Anti-bacterial compositions |
| JPH11217211A (en) * | 1998-01-30 | 1999-08-10 | Shiseido Co Ltd | Sol composition |
| JPH11228325A (en) * | 1998-02-17 | 1999-08-24 | Hiromi Nishii | Liquid composition containing plant extract |
| JPH11279023A (en) * | 1998-03-30 | 1999-10-12 | Shiseido Co Ltd | Composition for external use |
| JPH11302147A (en) * | 1998-04-17 | 1999-11-02 | Nippon Zetokku Kk | Cosmetic |
| JPH11335258A (en) * | 1998-05-19 | 1999-12-07 | Fancl Corp | Cosmetics |
| JP2000273004A (en) * | 1999-03-19 | 2000-10-03 | Nicca Chemical Co Ltd | Germicidal disinfectant composition |
| JP2001048800A (en) * | 1999-08-05 | 2001-02-20 | Mitsui Norin Co Ltd | Antifungal agent effective against drug-resistant fungi, low-acid beverage containing the same, and method for producing the same |
| JP2001206816A (en) * | 1999-11-19 | 2001-07-31 | Frontier:Kk | Milky lotion having skin-softening property and antimicrobial activity, cosmetic preparation and skin- cleansing article |
| JP2002504114A (en) * | 1997-06-04 | 2002-02-05 | ザ、プロクター、エンド、ギャンブル、カンパニー | Antibacterial, mild rinse-off liquid cleaning composition |
| JP2002223734A (en) * | 2002-01-21 | 2002-08-13 | Mitsui Norin Co Ltd | Low-acid beverage containing antifungal agent effective against drug-resistant fungus and method for producing the same |
| JP2002316922A (en) * | 2001-04-16 | 2002-10-31 | Magunooru:Kk | Skin cleansing agent containing extract from aralia cordata |
| JP2003081759A (en) * | 2001-09-13 | 2003-03-19 | Shiseido Co Ltd | Water-in-oil emulsified composition |
| WO2006067875A1 (en) * | 2004-12-22 | 2006-06-29 | Yamachu Co., Ltd. | Anti-uv aqueous cosmetic composition |
| JP2006249049A (en) * | 2005-03-14 | 2006-09-21 | Shiseido Co Ltd | Skin care composition |
| JP2008100923A (en) * | 2006-10-17 | 2008-05-01 | Kao Corp | Antiseptic disinfectant and external composition for skin |
| WO2008065734A1 (en) * | 2006-11-27 | 2008-06-05 | Oct Incorporated | Aqueous composition |
| JPWO2007015453A1 (en) * | 2005-08-01 | 2009-02-19 | マルホ株式会社 | Lotion containing a pyridonecarboxylic acid derivative |
| KR20100051450A (en) * | 2008-11-07 | 2010-05-17 | (주)아모레퍼시픽 | Mild composition for skin external application under the weak acid conditions |
| KR20160058780A (en) | 2013-09-25 | 2016-05-25 | 다이헤이요 세멘토 가부시키가이샤 | Method for producing metal hydride |
-
1994
- 1994-06-08 JP JP12635894A patent/JPH07330505A/en active Pending
Cited By (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0920630A (en) * | 1995-07-06 | 1997-01-21 | Nippon Zetotsuku Kk | Cosmetic material |
| JPH0952814A (en) * | 1995-08-09 | 1997-02-25 | Sunstar Inc | Skin cosmetic composition |
| EP0771561A3 (en) * | 1995-10-30 | 1999-03-17 | Beiersdorf Aktiengesellschaft | Antimycotic compositions, especially active against dandruff, containing aromatic alcohols |
| US5900258A (en) * | 1996-02-01 | 1999-05-04 | Zeolitics Inc. | Anti-bacterial compositions |
| JPH09255519A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH09255517A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH09255518A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
| JPH1053510A (en) * | 1996-05-27 | 1998-02-24 | Shiseido Co Ltd | Composition for external use |
| JPH1045556A (en) * | 1996-08-02 | 1998-02-17 | Noevir Co Ltd | Antimicrobial and low-irritant cosmetic |
| JPH1045562A (en) * | 1996-08-08 | 1998-02-17 | Noevir Co Ltd | Antimicrobial and low-irritant cosmetic |
| JPH10139601A (en) * | 1996-11-13 | 1998-05-26 | Noevir Co Ltd | Antimicrobial and antimicrobial cosmetic material containing the same |
| JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
| JPH10194923A (en) * | 1997-01-13 | 1998-07-28 | Nippon Zetotsuku Kk | Emulsified composition |
| JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
| JPH10194948A (en) * | 1997-01-17 | 1998-07-28 | Nippon Shizen Shokuhin Kk | Skin lotion |
| JPH10203955A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| JPH10203991A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Preparation for external use for skin |
| JPH10279417A (en) * | 1997-04-01 | 1998-10-20 | Shiseido Co Ltd | Preparation for external use for skin |
| JP2002504114A (en) * | 1997-06-04 | 2002-02-05 | ザ、プロクター、エンド、ギャンブル、カンパニー | Antibacterial, mild rinse-off liquid cleaning composition |
| JPH1180781A (en) * | 1997-09-11 | 1999-03-26 | Narisu Keshohin:Kk | Cleaning composition for atopic dermatitis |
| JPH11217211A (en) * | 1998-01-30 | 1999-08-10 | Shiseido Co Ltd | Sol composition |
| JPH11228325A (en) * | 1998-02-17 | 1999-08-24 | Hiromi Nishii | Liquid composition containing plant extract |
| JPH11279023A (en) * | 1998-03-30 | 1999-10-12 | Shiseido Co Ltd | Composition for external use |
| JPH11302147A (en) * | 1998-04-17 | 1999-11-02 | Nippon Zetokku Kk | Cosmetic |
| JPH11335258A (en) * | 1998-05-19 | 1999-12-07 | Fancl Corp | Cosmetics |
| JP2000273004A (en) * | 1999-03-19 | 2000-10-03 | Nicca Chemical Co Ltd | Germicidal disinfectant composition |
| JP2001048800A (en) * | 1999-08-05 | 2001-02-20 | Mitsui Norin Co Ltd | Antifungal agent effective against drug-resistant fungi, low-acid beverage containing the same, and method for producing the same |
| JP2001206816A (en) * | 1999-11-19 | 2001-07-31 | Frontier:Kk | Milky lotion having skin-softening property and antimicrobial activity, cosmetic preparation and skin- cleansing article |
| JP2002316922A (en) * | 2001-04-16 | 2002-10-31 | Magunooru:Kk | Skin cleansing agent containing extract from aralia cordata |
| JP2003081759A (en) * | 2001-09-13 | 2003-03-19 | Shiseido Co Ltd | Water-in-oil emulsified composition |
| JP2002223734A (en) * | 2002-01-21 | 2002-08-13 | Mitsui Norin Co Ltd | Low-acid beverage containing antifungal agent effective against drug-resistant fungus and method for producing the same |
| WO2006067875A1 (en) * | 2004-12-22 | 2006-06-29 | Yamachu Co., Ltd. | Anti-uv aqueous cosmetic composition |
| JP2006249049A (en) * | 2005-03-14 | 2006-09-21 | Shiseido Co Ltd | Skin care composition |
| JPWO2007015453A1 (en) * | 2005-08-01 | 2009-02-19 | マルホ株式会社 | Lotion containing a pyridonecarboxylic acid derivative |
| US8778965B2 (en) | 2005-08-01 | 2014-07-15 | Maruho Co., Ltd. | Lotion preparation containing pyridonecarboxylic acid derivative |
| JP2008100923A (en) * | 2006-10-17 | 2008-05-01 | Kao Corp | Antiseptic disinfectant and external composition for skin |
| WO2008065734A1 (en) * | 2006-11-27 | 2008-06-05 | Oct Incorporated | Aqueous composition |
| KR20100051450A (en) * | 2008-11-07 | 2010-05-17 | (주)아모레퍼시픽 | Mild composition for skin external application under the weak acid conditions |
| KR20160058780A (en) | 2013-09-25 | 2016-05-25 | 다이헤이요 세멘토 가부시키가이샤 | Method for producing metal hydride |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH07330505A (en) | Antimicrobial composition | |
| CN102573851B (en) | Broad spectrum preservation blends | |
| US20100029780A1 (en) | Topical composition | |
| EP2937101A1 (en) | Semi-fluidic composition for lubricating, moisture retaining, disinfecting, sterilizing and method using the same | |
| WO2004028520A1 (en) | Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides | |
| JP2018527320A (en) | Antimicrobial compositions and formulations that release hydrogen peroxide | |
| CN113631155B (en) | Disinfectant composition, preparation method and use thereof | |
| CN114515251A (en) | Composition for removing acne and repairing acne and preparation method thereof | |
| US20260034092A1 (en) | Biocidal composition | |
| JP6971518B2 (en) | Antibacterial composition containing thymol, terpineol, and cationic phospholipids | |
| WO2008104076A1 (en) | Electrocolloidal silver and echinacea root antimicrobial formulation | |
| KR102241761B1 (en) | A composition having a fast-acting sterilizing effect at room temperature | |
| WO2016030609A1 (en) | Antimicrobial composition | |
| KR101674512B1 (en) | Cosmetic composition with effect of proliferation of lactic acid bacteria and anti-bacterial activity and manufacturing method thereof | |
| WO2019002400A1 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an aromatic alcohol, and cosmetic composition containing same | |
| JP2007217394A (en) | Pharmaceutical composition | |
| US8486459B2 (en) | Bulbine frutescens extract | |
| JP2007284412A (en) | Disinfectant disinfection cream | |
| CN100360016C (en) | A foot sanitizer | |
| KR102482158B1 (en) | gel composition for disinfection and manufacturing method thereof | |
| CN100431419C (en) | Biological agent for foot disinfection | |
| JPH0536404B2 (en) | ||
| KR102717109B1 (en) | antibacterial composition for cosmetic products with Zinc Oxide | |
| AU2006235798B2 (en) | Topical composition | |
| JP2004196758A (en) | External preparation composition for prophylaxis and treatment of mucocutaneous inflammation of livestock and pet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040427 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040628 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20041130 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050126 |
|
| A02 | Decision of refusal |
Effective date: 20050802 Free format text: JAPANESE INTERMEDIATE CODE: A02 |
|
| A521 | Written amendment |
Effective date: 20050926 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20051019 |
|
| A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Effective date: 20051202 Free format text: JAPANESE INTERMEDIATE CODE: A912 |